Tue, October 27, 2009
[ Tue, Oct 27th 2009 ] - Market Wire
GlaxoSmithKline and Theravance commence Phase III .. e to develop a next-generation treatment for COPD
[ Tue, Oct 27th 2009 ] - Market Wire
Oncolytics(R) Biotech Inc. Announces Issuance of 33rd U.S. Patent
[ Tue, Oct 27th 2009 ] - Market Wire
QLT Announces Share Repurchase Program
[ Tue, Oct 27th 2009 ] - Market Wire
BIOLASE to Present at the AeA Classic Financial Conference in San Diego, CA
[ Tue, Oct 27th 2009 ] - Market Wire
QLT announces third quarter results for 2009
Mon, October 26, 2009
[ Mon, Oct 26th 2009 ] - Market Wire
Pharming to present at Bio-Europe 2009
[ Mon, Oct 26th 2009 ] - Market Wire
Salix Pharmaceuticals Previews American College of Gastroenterology 2009 Annual Scientific Meeting
[ Mon, Oct 26th 2009 ] - Market Wire
Stellar Pharmaceuticals Signs Licensing Agreement .. istribution And Sale of Uracyst(R) in South Korea
[ Mon, Oct 26th 2009 ] - Market Wire
AVI BioPharma Presents Updated Safety Data From O .. -4658 at 7th Annual Action Duchenne International
[ Mon, Oct 26th 2009 ] - Market Wire
Oncolytics Biotech(R) Inc. Announces Results of First Warrant Expiry Date Acceleration Program
[ Mon, Oct 26th 2009 ] - Market Wire
BIOLASE Names Gregory D. Waller to Board of Directors
Sun, October 25, 2009
[ Sun, Oct 25th 2009 ] - Market Wire
San West, Inc. Announces 5-for-1 Forward Split Record Date Set for Close of Business October 26th
Fri, October 23, 2009
[ Fri, Oct 23rd 2009 ] - Market Wire
&;AElig;terna Zentaris Receives US$5.5 Million from Institutional Investors
[ Fri, Oct 23rd 2009 ] - Market Wire
Unilife Secures US$5.2m in Pennsylvania Job Creation Program Funds to Fuel Corporate Expansion
[ Fri, Oct 23rd 2009 ] - Market Wire
Unilife Secures US$5.2m in Pennsylvania Job Creation Program Funds to Fuel Corporate Expansion
[ Fri, Oct 23rd 2009 ] - Market Wire
Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2009
[ Fri, Oct 23rd 2009 ] - Market Wire
Lpath, Inc.: Lpath to Present at the 2009 BIOCOM Investor Conference
[ Fri, Oct 23rd 2009 ] - Market Wire
MoneyTV; BioTime, Inc.; Cord Blood America, Inc.; .. en Baron Report; Brewer Investment Group; Skyline
Thu, October 22, 2009
[ Thu, Oct 22nd 2009 ] - Market Wire
MMR Information Systems, Inc.: MMR Information Sy .. ysicians With Kodak in Attendance November 4-5 at
[ Thu, Oct 22nd 2009 ] - Market Wire
Pharming recombinant human C1 inhibitor: Results .. erfusion model confirm potential for new indicati
[ Thu, Oct 22nd 2009 ] - Market Wire
Atrium Innovations to Hold 2009 Third Quarter Fin .. ults Conference Call and Webcast on November 11th
[ Thu, Oct 22nd 2009 ] - Market Wire
Eurand N.V.: Eurand Announces Pricing of Offering of Ordinary Shares
[ Thu, Oct 22nd 2009 ] - Market Wire
SemBioSys enters into commercialization and supply agreement for plant-made chymosin protein
[ Thu, Oct 22nd 2009 ] - Market Wire
Digirad: Digirad Corporation Reports Third Quarter 2009 Financial Results
Wed, October 21, 2009
[ Wed, Oct 21st 2009 ] - Market Wire
Meridian Medical Inc.: Meridian Medical Inc. Expands Sales in Southern United States
[ Wed, Oct 21st 2009 ] - Market Wire
HearUSA, Inc.: HearUSA Sets Third Quarter 2009 Co .. nce Call for Tuesday, November 10 at 4:30 p.m. ET
[ Wed, Oct 21st 2009 ] - Market Wire
Metro One Development, Inc. and Imagin8: Metro On .. oyment of Two Interactive Floors in Leading Shopp
[ Wed, Oct 21st 2009 ] - Market Wire
Crucell N.V.: Crucell HIV Vaccine: Promising Prel .. Presented by Dr Dan Barouch at AIDS Vaccine 2009
[ Wed, Oct 21st 2009 ] - Market Wire
Reflect Scientific: Reflect Scientific, Inc. Cont .. onsulting, LLC to Provide Investor Relations Serv
[ Wed, Oct 21st 2009 ] - Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Announce .. ent in Its Phase 2 Trial of SCV-07 in Hepatitis C
Tue, October 20, 2009
[ Tue, Oct 20th 2009 ] - Market Wire
PharmaGap Inc.: PharmaGap Advises That NCI Test R .. nd Expected to Be Provided to the Company Shortly
[ Tue, Oct 20th 2009 ] - Market Wire
Baywood International, Inc.: Life Is a Whole Lot .. the Addition of New Leaf's "Sweet Tea"
[ Tue, Oct 20th 2009 ] - Market Wire
Given Imaging: Given Imaging to Host Third Quarter 2009 Financial Results Conference Calls
[ Tue, Oct 20th 2009 ] - Market Wire
Lpath, Inc.: Lpath Receives Grants From the Natio .. Publishes Key Paper in the Proceedings of the Nat
[ Tue, Oct 20th 2009 ] - Market Wire
Akela Pharma announces director resignation
[ Tue, Oct 20th 2009 ] - Market Wire
Sernova Corp.: Sernova's Cell Pouch System(TM) an .. ficacy Presented at Leading International Islet T
Mon, October 19, 2009
[ Mon, Oct 19th 2009 ] - Market Wire
Baywood International: Baywood International, Inc .. ands Inc., Begins Trading Under New Symbol "
[ Mon, Oct 19th 2009 ] - Market Wire
Facet Biotech Corporation: Facet Biotech's Board .. holders Continue to Reject Biogen Idec's Tender O
[ Mon, Oct 19th 2009 ] - Market Wire
Daxor Corp.: Daxor Announces That Durham VA Medic .. ood Volume Analyzer to Assess Obesity-Related Hem
[ Mon, Oct 19th 2009 ] - Market Wire
AVI BioPharma, Inc.: Exon Skipping Therapy Shows .. y of Heart Disease Associated With Duchenne Muscu
[ Mon, Oct 19th 2009 ] - Market Wire
Hansen Medical, Inc.: Hansen Medical Announces Need to Restate Prior Financial Results
[ Mon, Oct 19th 2009 ] - Market Wire
&;AElig;terna Zentaris to Complete Phase 3 Clinic .. -130) as First Oral Diagnostic Test for Growth Ho
Fri, October 16, 2009
[ Fri, Oct 16th 2009 ] - Market Wire
DIAGNOS Inc.: DIAGNOS Inc.: Clarification of Prev .. usly Issued Press Release Dated October 5th, 2009
[ Fri, Oct 16th 2009 ] - Market Wire
Insulet: Insulet Corporation to Report Third Quar .. 009 Financial Results on Monday, October 26, 2009
[ Fri, Oct 16th 2009 ] - Market Wire
Chembio Diagnostics, Inc.: Chembio Diagnostics to .. Kits to Orangutan Rehabilitation Centers in Born
[ Fri, Oct 16th 2009 ] - Market Wire
TomoTherapy: TomoTherapy to Announce Third-Quarter Results on Wednesday, October 28, 2009
[ Fri, Oct 16th 2009 ] - Market Wire
Cancer Therapeutics, Inc.: Cancer Therapeutics Announces Letter of Intent With NanoTherapies, LLC
[ Fri, Oct 16th 2009 ] - Market Wire
Digirad: Digirad Introduces c.pax(TM) for Cardiology
Thu, October 15, 2009
[ Thu, Oct 15th 2009 ] - Market Wire
TomoTherapy: Institute Curie Hospital Purchases Second TomoTherapy(R) Radiation Therapy System
[ Thu, Oct 15th 2009 ] - Market Wire
InfuSystem Holdings, Inc.: InfuSystem Announces O .. tanding Results in Customer Satisfaction Research
[ Thu, Oct 15th 2009 ] - Market Wire
Stellar Pharmaceuticals Inc.: Stellar Pharmaceuti .. of Positive Presentation at Major Urology Confere
[ Thu, Oct 15th 2009 ] - Market Wire
Vasogen Announces Third Quarter 2009 Results
[ Thu, Oct 15th 2009 ] - Market Wire
Radient Pharmaceuticals Corporation: Radient Phar .. Research Collaboration Agreement With CeTeCancer
[ Thu, Oct 15th 2009 ] - Market Wire
Eurand N.V.: Eurand Announces Proposed Public Offering of Ordinary Shares
Wed, October 14, 2009
[ Wed, Oct 14th 2009 ] - Market Wire
MMR Information Systems, Inc.: MMR Information Sy .. tegration of MMR PHR and MMRPro in Development Pr
[ Wed, Oct 14th 2009 ] - Market Wire
Edwards Lifesciences : Edwards Lifesciences to Host Earnings Conference Call on October 21, 2009
[ Wed, Oct 14th 2009 ] - Market Wire
AspenBio Pharma, Inc.: AspenBio Pharma Fills Key Animal Health and Quality Leadership Positions
[ Wed, Oct 14th 2009 ] - Market Wire
AspenBio Pharma, Inc.: AspenBio Pharma Announces .. ing of Public Offering of 5,155,000 Common Shares
[ Wed, Oct 14th 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. arter 2009 Results and Conduct Conference Call on
[ Wed, Oct 14th 2009 ] - Market Wire
Trinity Biotech Plc: Trinity Biotech plc to Annou .. uarter 2009 Financial Results on October 21, 2009
Tue, October 13, 2009
[ Tue, Oct 13th 2009 ] - Market Wire
Galapagos NV: Galapagos expands strategic alliance in metabolic disease with Merck & Co., Inc.
[ Tue, Oct 13th 2009 ] - Market Wire
Pharming Group N.V.: Pharming confirms successful closing of offer on convertible bonds
[ Tue, Oct 13th 2009 ] - Market Wire
Antisense: Antisense Therapeutics Announces ATL1103 on Track to Move Into Clinical Development
[ Tue, Oct 13th 2009 ] - Market Wire
Corcept Therapeutics: Corcept Therapeutics Announ .. ent Cash Sufficient to Fund Company Through Corlu
[ Tue, Oct 13th 2009 ] - Market Wire
Watson Pharmaceuticals, Inc.: Watson to Host Thir .. Quarter 2009 Earnings Conference Call and Webcast
[ Tue, Oct 13th 2009 ] - Market Wire
FONAR Corporation: FONAR Continues Growth With Tw .. IGHT Multi-Position MRI to U.S. Medical Practices
Mon, October 12, 2009
[ Mon, Oct 12th 2009 ] - Market Wire
San West, Inc.: San West, Inc. Declares Five-for-One Stock-Split
[ Mon, Oct 12th 2009 ] - Market Wire
iBio, Inc.: iBio to Present Advantages of Plant-B .. International Association for Biologicals Confer
[ Mon, Oct 12th 2009 ] - Market Wire
Bio-Rad Laboratories: Bio-Rad to Report Third-Qua .. 2009 Financial Results Tuesday, November 3, 2009
[ Mon, Oct 12th 2009 ] - Market Wire
TomoTherapy: TomoTherapy to Host Analyst and Inve .. tor Presentation at 2009 ASTRO Meeting in Chicago
[ Mon, Oct 12th 2009 ] - Market Wire
XTend Medical Corporation : XTend Medical (XMDC) .. cusses BioHarp Market Potential and Revenue Model
[ Mon, Oct 12th 2009 ] - Market Wire
MDRNA Inc.: MDRNA Reports UsiRNA Reduces Tumor Growth In Vivo
Fri, October 9, 2009
[ Fri, Oct 09th 2009 ] - Market Wire
San West, Inc.: San West, Inc. (SNWT) Enters Into .. nership With Second Largest Online Dealer in U.S.
[ Fri, Oct 09th 2009 ] - Market Wire
FONAR Corporation: FONAR Deemed Compliant With Al .. ng Standards; FONAR Complies With NASDAQ Marketpl
[ Fri, Oct 09th 2009 ] - Market Wire
Amarillo Biosciences, Inc.: Amarillo Biosciences .. Supporting Use of Interferon to Combat Influenza
[ Fri, Oct 09th 2009 ] - Market Wire
Horizon Health International Corp.: Retransmissio .. n Health International Corp. Announces New Symbol
[ Fri, Oct 09th 2009 ] - Market Wire
San West, Inc.: San West Inc. (SNWT) Provides His .. te Announcements, Comments on Recent Developments
[ Fri, Oct 09th 2009 ] - Market Wire
MedaSorb Technologies Corporation: MedaSorb Techn .. oration Raises $1.3M in Series B Warrant Exercise
Thu, October 8, 2009
[ Thu, Oct 08th 2009 ] - Market Wire
Edwards Lifesciences: Edwards Lifesciences to Expand Its Manufacturing and R&D Capability
[ Thu, Oct 08th 2009 ] - Market Wire
DIAGNOS Inc.: DIAGNOS Announces Memorandum of Understanding with Zeiss Canada Ltd
[ Thu, Oct 08th 2009 ] - Market Wire
ALDA Pharmaceuticals Corp.: ALDA Enters Into Supplier Agreement With Acklands-Grainger Inc.
[ Thu, Oct 08th 2009 ] - Market Wire
The Medicines Company: The Medicines Company Announces Second New Patent Issuance for Angiomax(R)
[ Thu, Oct 08th 2009 ] - Market Wire
BIOLASE Technology, Inc.: BIOLASE Wins Deloitte Tech Evolution Award
[ Thu, Oct 08th 2009 ] - Market Wire
Health This Week with Don Baillargeon; Orange Cou .. ing3, Inc.; Delgado Protocol; Francois Allyn Chef
Wed, October 7, 2009
[ Wed, Oct 07th 2009 ] - Market Wire
FONAR Corporation: NASDAQ Continues to Review FONAR's Compliance With Listing Requirements
[ Wed, Oct 07th 2009 ] - Market Wire
Amarillo Biosciences, Inc.: Amarillo Biosciences .. Intas Pharmaceuticals to Treat Influenza in India
[ Wed, Oct 07th 2009 ] - Market Wire
Daxor Corp.: Daxor Announces That Susquehanna Hea .. msport, PA Acquires BVA-100 Blood Volume Analyzer
[ Wed, Oct 07th 2009 ] - Market Wire
AspenBio Pharma, Inc.: AspenBio Pharma Announces Public Offering of 4,482,609 Common Shares
[ Wed, Oct 07th 2009 ] - Market Wire
Anaconda Mining Inc.: RETRANSMISSION: Anaconda Mining Announces Changes to Its Board of Directors
[ Wed, Oct 07th 2009 ] - Market Wire
Sernova Corp.: Sernova Corp. Announces Private Placement
Tue, October 6, 2009
[ Tue, Oct 06th 2009 ] - Market Wire
Allana Resources Inc.: Allana Resources Announces .. ruction Initiated at Its Ethiopian Potash Project
[ Tue, Oct 06th 2009 ] - Market Wire
Vicor Technologies, Inc.: Trial Findings for Vico .. gn Diagnostic to Be Presented at the American Hea
[ Tue, Oct 06th 2009 ] - Market Wire
Micro Imaging Technology, Inc.: Micro Imaging Tec .. ing Commitment of up to $3,000,000 From Ascendian
[ Tue, Oct 06th 2009 ] - Market Wire
CONMED Corporation: CONMED Corporation to Announc .. uarter 2009 Financial Results on October 22, 2009
[ Tue, Oct 06th 2009 ] - Market Wire
The Medicines Company: The Medicines Company Anno .. s Preliminary Third Quarter 2009 Top Line Results
[ Tue, Oct 06th 2009 ] - Market Wire
Sanguine Corporation: Sanguine Subsidiary to Chan .. From Sanguine Life Sciences to SGN Life Sciences
Mon, October 5, 2009
[ Mon, Oct 05th 2009 ] - Market Wire
FONAR Corporation: FONAR Reports Fiscal 2009 Year-End Financial Results
[ Mon, Oct 05th 2009 ] - Market Wire
ALDA Pharmaceuticals Corp.: ALDA Enters Into Vendor Agreement With London Drugs
[ Mon, Oct 05th 2009 ] - Market Wire
Eurand N.V.: Eurand Announces Conference Call on Third Quarter 2009 Financial Results
[ Mon, Oct 05th 2009 ] - Market Wire
Molecular Insight Pharmaceuticals, Inc. : Molecul .. esents Azedra(TM) 12-Month Efficacy Data From Pha
[ Mon, Oct 05th 2009 ] - Market Wire
AVI BioPharma, Inc.: AVI BioPharma Receives Expan .. ment of Defense to Develop Its Drug Candidate for
[ Mon, Oct 05th 2009 ] - Market Wire
Novo Nordisk A/S: Novo Nordisk: Transaction in Own Shares
Sun, October 4, 2009
[ Sun, Oct 04th 2009 ] - Market Wire
Hansen Medical, Inc.: Hansen Medical Showcases Ne .. ated Ablation Catheter at Venice Arrhythmias 2009
Fri, October 2, 2009
[ Fri, Oct 02nd 2009 ] - Market Wire
Sierra Geothermal Power Corp.: SGP Receives Letter Requisitioning a Shareholder Meeting
[ Fri, Oct 02nd 2009 ] - Market Wire
Constellation Software Inc.: Constellation Software Announces an Increase in Credit Facility
[ Fri, Oct 02nd 2009 ] - Market Wire
SciClone Pharmaceuticals, Inc.: Phase 2 Trial of .. P101 in Late-Stage Pancreatic Cancer Discontinued
[ Fri, Oct 02nd 2009 ] - Market Wire
The Medicines Company: The Medicines Company Anno .. es the Resignation of Its Chief Operating Officer
[ Fri, Oct 02nd 2009 ] - Market Wire
Omni Bio Pharmaceutical: Dr. Charles A. Dinarello .. o and Acting CEO of Omni Bio Pharmaceutical to Be
Thu, October 1, 2009
[ Thu, Oct 01st 2009 ] - Market Wire
Given Imaging: Given Imaging's PillCam(R) SB and .. Patency System Cleared for Use in Young Children
[ Thu, Oct 01st 2009 ] - Market Wire
TomoTherapy: Methodist Medical Center and Midwest .. tate Cancer With New TomoTherapy(R) Radiation The
[ Thu, Oct 01st 2009 ] - Market Wire
XTend Medical Corporation : XTend Medical (XMDC) .. gns Letter of Intent to Merge With BioHarp, Korea
[ Thu, Oct 01st 2009 ] - Market Wire
Theravance, Inc.: Astellas and Theravance Announc .. lavancin) in Canada for the Treatment of Complica
[ Thu, Oct 01st 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. 5 Million Shares of Common Stock Resulting in $11
[ Thu, Oct 01st 2009 ] - Market Wire
TSO3 files patent applications to extend protecti .. r sterilizationcycles with improved compatibility
Wed, September 30, 2009
[ Wed, Sep 30th 2009 ] - Market Wire
Welichem Announces Filing of Phase II Multi-centre Clinical Trial Application
[ Wed, Sep 30th 2009 ] - Market Wire
Constellation Software Inc.: Constellation Extend .. of Public Transit Solutions Segment From Contine
[ Wed, Sep 30th 2009 ] - Market Wire
Cancer Therapeutics, Inc.: Cancer Therapeutics Names Dr. Mark Kester to Advisory Board
[ Wed, Sep 30th 2009 ] - Market Wire
ImmuCell Corporation: ImmuCell's Mastitis Drug Meets Pivotal Effectiveness Study End Point
[ Wed, Sep 30th 2009 ] - Market Wire
Galea Life Sciences, Inc.: Galea Life Sciences, I .. nnounces Filing of Form 10 Registration Statement
[ Wed, Sep 30th 2009 ] - Market Wire
Sernova Corp.: Sernova to Present Research Result .. Leading International Islet Transplant Conference
Tue, September 29, 2009
[ Tue, Sep 29th 2009 ] - Market Wire
Crucell N.V.: Crucell Strengthens its Vaccine Sal .. with a Dedicated Marketing and Sales Organization
[ Tue, Sep 29th 2009 ] - Market Wire
Diagnos Inc.: DIAGNOS Announces Memorandum of Understanding with ISee3D Inc.
[ Tue, Sep 29th 2009 ] - Market Wire
Medtronic, Inc.: Innovative Device Provides More .. ally-Invasive Option for Potentially Fatal, Often
[ Tue, Sep 29th 2009 ] - Market Wire
Vicor Technologies, Inc.: Vicor Technologies Issu .. Altered State Physiology Drug Development Platfor
[ Tue, Sep 29th 2009 ] - Market Wire
Marshall Edwards, Inc.: Marshall Edwards, Inc.'s .. r, Demonstrates Good Safety Profile and High Anti
[ Tue, Sep 29th 2009 ] - Market Wire
MDRNA, Inc.: MDRNA Announces Patent Allowance Cov .. utic Potential for Oncology and Other Indications
Mon, September 28, 2009
[ Mon, Sep 28th 2009 ] - Market Wire
InfuSystem Holdings, Inc.: InfuSystem Holdings to .. t JMP Securities 2009 Healthcare Focus Conference
[ Mon, Sep 28th 2009 ] - Market Wire
Centric Energy Corp.: Centric Energy-Board Appointments
[ Mon, Sep 28th 2009 ] - Market Wire
Insulet Corporation: Insulet Amends Deerfield Credit Facility and Issues Stock
[ Mon, Sep 28th 2009 ] - Market Wire
Allana Resources Inc.: Allana Resources Appoints .. n as Project Manager for Ethiopian Potash Project
[ Mon, Sep 28th 2009 ] - Market Wire
San West, Inc.: San West, Inc. (SNWT) Announces New Symbol and Name Change
[ Mon, Sep 28th 2009 ] - Market Wire
BIOLASE Technology, Inc.: BIOLASE Announces Distribution Agreements in China
Fri, September 25, 2009
[ Fri, Sep 25th 2009 ] - Market Wire
Amador Gold Corp.: Amador Gold Corp. Announces Pr .. sed Drilling Plans on Three Timmins Gold Projects
[ Fri, Sep 25th 2009 ] - Market Wire
Insulet Corporation: Insulet Corporation to Prese .. at the JMP Securities Healthcare Focus Conference
[ Fri, Sep 25th 2009 ] - Market Wire
Diagnos Inc.: DIAGNOS Announces Appointment to Scientific Advisory Board
[ Fri, Sep 25th 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. nces Pricing of a Public Offering of Common Stock
[ Fri, Sep 25th 2009 ] - Market Wire
YM BIOSCIENCES REPORTS FISCAL YEAR END 2009 OPERATIONAL AND FINANCIAL RESULTS
Thu, September 24, 2009
[ Thu, Sep 24th 2009 ] - Market Wire
Marani Brands, Inc.: Marani Brands to Begin Sales and Distribution in India
[ Thu, Sep 24th 2009 ] - Market Wire
iCo Therapeutics Signs Collaboration Agreement with The Consortium for Parasitic Drug Development
[ Thu, Sep 24th 2009 ] - Market Wire
Southern California Investment Association: SCIA' .. rence October 3rd, 2009, Hilton Hotel, Irvine, CA
[ Thu, Sep 24th 2009 ] - Market Wire
San West, Inc.: San West, Inc. Awarded Exclusive TrophyKart Dealer for San Diego
[ Thu, Sep 24th 2009 ] - Market Wire
IGSM GROUP INC.: IGSM to Launch First E-Learning Product
Wed, September 23, 2009
[ Wed, Sep 23rd 2009 ] - Market Wire
Galapagos NV: Galapagos announces expanded drug discovery collaboration with Schering-Plough
[ Wed, Sep 23rd 2009 ] - Market Wire
Pharming Group N.V.: Pharming's Marketing Authori .. Validated by the European Medicines Agency (EMEA
[ Wed, Sep 23rd 2009 ] - Market Wire
Edwards Lifesciences: Federal Court Finds Edwards .. ces' Patents for Endovascular Graft Not Infringed
[ Wed, Sep 23rd 2009 ] - Market Wire
BiomedReports.Com: Intriguing Revelations: Deciphering CEL-SCI's H1N1 Flu Play
[ Wed, Sep 23rd 2009 ] - Market Wire
Amador Gold Corp.: Amador Gold Corp. Acquires Gol .. st Timmins Camp Along Destor-Porcupine Fault Zone
Tue, September 22, 2009
[ Tue, Sep 22nd 2009 ] - Market Wire
GeneThera: GeneThera Finalizes License and Resear .. Italian Universities; Agreement Represents Key S
[ Tue, Sep 22nd 2009 ] - Market Wire
GeneThera: GeneThera Finalizes License and Resear .. Italian Universities; Agreement Represents Key S
[ Tue, Sep 22nd 2009 ] - Market Wire
MMR Information Systems, Inc.: MMR Information Sy .. arketing Partnership for More Than One Billion Co
[ Tue, Sep 22nd 2009 ] - Market Wire
Genomic Health: Genomic Health Confirms Consisten .. (R) Recurrence Score(R) Across European, Middle E
[ Tue, Sep 22nd 2009 ] - Market Wire
Genomic Health: Genomic Health Confirms Consisten .. (R) Recurrence Score(R) Across European, Middle E
Mon, September 21, 2009
[ Mon, Sep 21st 2009 ] - Market Wire
Burcon Receives Notice of Allowance from the United States Patent andTrademark Office
[ Mon, Sep 21st 2009 ] - Market Wire
Diagnostic Imaging International Corp.: Diagnosti .. onal Corp.-CTS Signs New Client Hospital Contract
[ Mon, Sep 21st 2009 ] - Market Wire
Developers Diversified Realty Corporation: Develo .. rogress on De-Leveraging Initiatives and Provides
[ Mon, Sep 21st 2009 ] - Market Wire
Anaconda Mining Inc.: Anaconda Mining Provides Update on Pine Cove Operations
[ Mon, Sep 21st 2009 ] - Market Wire
Adeona Pharmaceuticals, Inc.: Adeona Provides 10, .. Water Copper Test Cards for World Alzheimer's Day
Fri, September 18, 2009
[ Fri, Sep 18th 2009 ] - Market Wire
BiomedReports.Com: CEL-SCI's CEO Says H1N1 Flu Dr .. g Candidate Could Propel Company Onto World Stage
[ Fri, Sep 18th 2009 ] - Market Wire
Hypertension Diagnostics: Hypertension Diagnostics Announces Fiscal Year 2009 Results
[ Fri, Sep 18th 2009 ] - Market Wire
Cytokinetics, Inc.: Cytokinetics Highlights Progr .. ment Programs at Today's Research and Development
Thu, September 17, 2009
[ Thu, Sep 17th 2009 ] - Market Wire
Syneron Medical Ltd.: Syneron Medical to Present .. es Conference and the Maxim Group Growth Conferen
[ Thu, Sep 17th 2009 ] - Market Wire
IDO Security, Inc.: IDO Announces Expansion of So .. eholder Communications Platform With BrandMediaPR
[ Thu, Sep 17th 2009 ] - Market Wire
PharmaGap Inc.: Ottawa Hospital Research Institut .. f PharmaGap's Novel Cancer Drug Formally Underway
[ Thu, Sep 17th 2009 ] - Market Wire
CONMED Corporation: CONMED Corporation to Present at the UBS Global Life Sciences Conference
[ Thu, Sep 17th 2009 ] - Market Wire
Premium Brands Holdings Corporation: Premium Bran .. ngs Corporation Announces September 2009 Dividend
Wed, September 16, 2009
[ Wed, Sep 16th 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: U.S. Food and Dru .. Advisory Committee Votes Unanimously 12-0 to Reco
[ Wed, Sep 16th 2009 ] - Market Wire
IDO Security, Inc.: IDO Security Announces R&D Jo .. ermany to Develop Explosive Substance Detection C
[ Wed, Sep 16th 2009 ] - Market Wire
Eurand N.V.: Eurand to Present at UBS Global Life Sciences Conference
[ Wed, Sep 16th 2009 ] - Market Wire
Smith & Nephew PLC: Smith & Nephew Announces the .. Ag Gentle and ALLEVYN Ag Gentle Border Antimicro
[ Wed, Sep 16th 2009 ] - Market Wire
Smith & Nephew Plc: Smith&Nephew-Global Launch Allevyn Range Extension
Tue, September 15, 2009
[ Tue, Sep 15th 2009 ] - Market Wire
Allana Resources Inc.: Allana's Chinese Partner S .. es Due Diligence and Receives Government Approval
[ Tue, Sep 15th 2009 ] - Market Wire
Baywood International, Inc.: New Leaf Expands Mid .. Adding Chain Store Presence in Iowa and Nebraska
[ Tue, Sep 15th 2009 ] - Market Wire
AVI BioPharma, Inc.: AVI BioPharma, Inc. Announce .. Presentations at Upcoming Investment Conferences
[ Tue, Sep 15th 2009 ] - Market Wire
Cytokinetics, Inc.: Cytokinetics Presents Phase I .. ecamtiv Mecarbil at the 2009 Heart Failure Societ
[ Tue, Sep 15th 2009 ] - Market Wire
Premium Brands Holdings Corporation: Premium Bran .. nces the Implementation of a Dividend Reinvestmen
Mon, September 14, 2009
[ Mon, Sep 14th 2009 ] - Market Wire
ConjuChem Announces Fiscal 2009 Third Quarter Financial Results
[ Mon, Sep 14th 2009 ] - Market Wire
AVI BioPharma, Inc.: AVI BioPharma, Inc. Demonstr .. Control via RNA-Based Therapeutics in Hemorrhagic
[ Mon, Sep 14th 2009 ] - Market Wire
Global Biotech Corp.: Wykanta Acquires Asian Distribution Rights for Global Biotech Products
[ Mon, Sep 14th 2009 ] - Market Wire
AVI BioPharma, Inc.: AVI BioPharma Presents Safet .. ystrophy at 14th Annual International Congress of
[ Mon, Sep 14th 2009 ] - Market Wire
Given Imaging: Given Imaging Announces Progress With Second-Generation PillCam(R) COLON
Fri, September 11, 2009
[ Fri, Sep 11th 2009 ] - Market Wire
Theravance, Inc.: Theravance and Astellas Announc .. (telavancin) for the Treatment of Complicated Sk
[ Fri, Sep 11th 2009 ] - Market Wire
Argenta Oil & Gas Inc.: Argenta Closes First Tranche of Private Placement
[ Fri, Sep 11th 2009 ] - Market Wire
AgraQuest: AgraQuest Partners With Alpharma to Bring New Technology to Animal Nutrition Sector
[ Fri, Sep 11th 2009 ] - Market Wire
Somatic Systems, Inc.: Somatic Systems, Inc. Post .. ncials and Upgrades Company Rating on Pink Sheets
[ Fri, Sep 11th 2009 ] - Market Wire
Cytokinetics, Inc.: Cytokinetics to Host a Research and Development Day on Friday, September 18th
Thu, September 10, 2009
[ Thu, Sep 10th 2009 ] - Market Wire
TomoTherapy: TomoTherapy to Offer Advanced Radiat .. erapy Solution to GNYHA Services Member Hospitals
[ Thu, Sep 10th 2009 ] - Market Wire
iBio, Inc.: iBio Completes $3 Million Private Placement
[ Thu, Sep 10th 2009 ] - Market Wire
Oncothyreon to present at BioCentury NewsMakers Conference
[ Thu, Sep 10th 2009 ] - Market Wire
Protox announces positive 12 month Phase 2 BPH results
[ Thu, Sep 10th 2009 ] - Market Wire
MDS Reports Third Quarter 2009 Financial Results
Wed, September 9, 2009
[ Wed, Sep 09th 2009 ] - Market Wire
Chembio Diagnostics, Inc.: Chembio to Present at .. & Renshaw's Eleventh Annual Healthcare Conference
[ Wed, Sep 09th 2009 ] - Market Wire
Midland Exploration Inc.: Midland Acquires a New .. d Property Along the South Porcupine-Destor Fault
[ Wed, Sep 09th 2009 ] - Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Pharmace .. to Present at Two September Investor Conferences
[ Wed, Sep 09th 2009 ] - Market Wire
BioSyntech presents BST-CarGel(R) Cartilage Repai .. 2009 World Congress on Osteoarthritis in Montreal
[ Wed, Sep 09th 2009 ] - Market Wire
Targeted Genetics: Targeted Genetics Corporation .. le of Manufacturing Assets to Genzyme Corporation
Tue, September 8, 2009
[ Tue, Sep 08th 2009 ] - Market Wire
Watson Pharmaceuticals: Watson to Present at the .. merica Merrill Lynch Global Healthcare Conference
[ Tue, Sep 08th 2009 ] - Market Wire
SCOR: Adjustment to the conversion/exchange ratio .. NE convertible bonds: 0.117 SCOR share per OCEANE
[ Tue, Sep 08th 2009 ] - Market Wire
Amarillo Biosciences, Inc.: Amarillo Biosciences' .. Study of Interferon as a Preventative Agent Again
[ Tue, Sep 08th 2009 ] - Market Wire
IMRIS receives FDA clearance for IMRISNV and IMRIScardio
[ Tue, Sep 08th 2009 ] - Market Wire
InternetArray, Inc.: BidSellBuy.com From InternetArray Provides Update on Business Model

Eurand N.V.: Eurand Announces Conference Call on Third Quarter 2009 Financial Results


//health-fitness.news-articles.net/content/2009/ .. all-on-third-quarter-2009-financial-results.html
Published in Health and Fitness on Monday, October 5th 2009 at 6:17 GMT by Market Wire   Print publication without navigation


AMSTERDAM, THE NETHERLANDS--(Marketwire - October 5, 2009) - Eurand N.V. (NASDAQ: [ EURX ]), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies, will host a conference call on Thursday, November 5, 2009 at 8:30 a.m. ET to discuss its third quarter 2009 financial results. The conference call will be hosted by Gearóid Faherty, Chairman and Chief Executive Officer, and Mario Crovetto, Chief Financial Officer. 

 The conference call schedule is as follows: 7:00 a.m. ET: Third quarter 2009 financial results released 8:20 a.m. ET: Dial in to participate in the conference call: -- US Participants dial 1-877-407-9039 -- International Participants dial +1-201-689-8470 8:30 a.m. ET: Conference call begins Call Replay: A replay of the call will be available until December 5, 2009. The Account Number is: 3055; Conference ID Number: 334294. -- US Participants dial 1-877-660-6853 -- International Participants dial +1-201-612-7415

A live webcast of the call will also be available from the Investor Relations section of the corporate web site at [ www.eurand.com ]. Following the live webcast, the archived version of the call will be available at the same URL until December 5, 2009.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking orally disintegrating tablet (ODT) formulations, and drug conjugation.

Eurand is a global company with facilities in the U.S. and Europe. For more information, visit [ www.eurand.com ].


Publication Contributing Sources